NCT05180695: HDM201 and Pazopanib in Patients With P53 Wild-type Advanced/Metastatic Soft Tissue Sarcomas
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 47 taking part
- Started
- 15 Apr 2022
- Primary completion
- Feb 2027
- Arms
- extension part : Soft-tissue sarcomas with MDM2 amplification, extension part : Soft-tissue sarcomas with no MDM2 amplification
- Results
- None posted
- 6 Jan 2022: Trial registered
- 15 Apr 2022: Trial started